MedPath
HSA Approval

QCIN CAPSULE 150 MG

SIN17046P

QCIN CAPSULE 150 MG

QCIN CAPSULE 150 MG

July 18, 2024

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSEA PHARMA CONSULTANCY PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01FF01

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

RENATA LIMITED

Active Ingredients

Clindamycin Hydrochloride eqv Clindamycin

150 mg

Clindamycin

Documents

Package Inserts

Qcin Capsule 150 mg PI.pdf

Approved: July 18, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

QCIN CAPSULE 150 MG - HSA Approval | MedPath